Christina Y. Yim

536 total citations
16 papers, 368 citations indexed

About

Christina Y. Yim is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Christina Y. Yim has authored 16 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Christina Y. Yim's work include Radiopharmaceutical Chemistry and Applications (3 papers), ATP Synthase and ATPases Research (3 papers) and Mitochondrial Function and Pathology (2 papers). Christina Y. Yim is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), ATP Synthase and ATPases Research (3 papers) and Mitochondrial Function and Pathology (2 papers). Christina Y. Yim collaborates with scholars based in United States, Spain and Canada. Christina Y. Yim's co-authors include Joanna K. Soczynska, Hanna O. Woldeyohannes, Roger S. McIntyre, Sidney H. Kennedy, Samantha S. Liauw, Mohammad Alsuwaidan, Elisa Brietzke, Michael J. Spinella, Sarah J. Freemantle and Janice Tam and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Christina Y. Yim

14 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christina Y. Yim United States 6 118 88 66 59 57 16 368
Abdullah Çim Türkiye 11 76 0.6× 128 1.5× 53 0.8× 71 1.2× 31 0.5× 21 402
Hyeon-Jin Kim South Korea 8 82 0.7× 76 0.9× 28 0.4× 64 1.1× 57 1.0× 25 456
Seung Chan Kim South Korea 10 62 0.5× 113 1.3× 23 0.3× 102 1.7× 45 0.8× 37 436
Kyosuke Yamanishi Japan 13 28 0.2× 195 2.2× 79 1.2× 52 0.9× 41 0.7× 45 525
Nattakarn Limphaibool Poland 8 47 0.4× 63 0.7× 27 0.4× 55 0.9× 31 0.5× 18 341
Qiaoyan Hu United States 11 116 1.0× 118 1.3× 24 0.4× 58 1.0× 26 0.5× 21 382
Francesco Rossi Italy 14 32 0.3× 107 1.2× 15 0.2× 76 1.3× 64 1.1× 30 510
Xiaolin Yang China 9 35 0.3× 95 1.1× 31 0.5× 24 0.4× 60 1.1× 24 330
Lolita S. Nidadavolu United States 9 25 0.2× 106 1.2× 24 0.4× 83 1.4× 37 0.6× 17 356
Tianzuo Li China 7 109 0.9× 78 0.9× 20 0.3× 44 0.7× 73 1.3× 12 325

Countries citing papers authored by Christina Y. Yim

Since Specialization
Citations

This map shows the geographic impact of Christina Y. Yim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Y. Yim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Y. Yim more than expected).

Fields of papers citing papers by Christina Y. Yim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Y. Yim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Y. Yim. The network helps show where Christina Y. Yim may publish in the future.

Co-authorship network of co-authors of Christina Y. Yim

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Y. Yim. A scholar is included among the top collaborators of Christina Y. Yim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Y. Yim. Christina Y. Yim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sato, Ai, Emma Guilbaud, Christina Y. Yim, et al.. (2025). Partial mitochondrial involvement in the antiproliferative and immunostimulatory effects of PT-112. OncoImmunology. 14(1). 2507245–2507245.
2.
Rajan, Arun, Tyler D. Ames, Christina Y. Yim, et al.. (2025). Abstract 5819: Anti-cancer immune effects of PT-112 monotherapy across two disease indications. Cancer Research. 85(8_Supplement_1). 5819–5819. 1 indexed citations
3.
Moreno‐Loshuertos, Raquel, Christina Y. Yim, Tyler D. Ames, et al.. (2024). Cancer cell-selective induction of mitochondrial stress and immunogenic cell death by PT-112 in human prostate cell lines. Journal of Translational Medicine. 22(1). 927–927. 4 indexed citations
4.
Bryce, Alan H., Daniel D. Karp, Scott T. Tagawa, et al.. (2023). A phase 2 study of immunogenic cell death inducer PT-112 in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 41(6_suppl). TPS292–TPS292. 3 indexed citations
5.
Yim, Christina Y., Hannah L. Johnson, Maureen G. Mancini, et al.. (2023). Abstract C128: PT-112, a novel immunogenic cell death inducer, causes ribosomal biogenesis inhibition and organelle stress in cancer cells. Molecular Cancer Therapeutics. 22(12_Supplement). C128–C128. 5 indexed citations
6.
Yim, Christina Y., Marta Martínez‐Júlvez, Raquel Moreno‐Loshuertos, et al.. (2022). PT-112 Induces Mitochondrial Stress and Immunogenic Cell Death, Targeting Tumor Cells with Mitochondrial Deficiencies. Cancers. 14(16). 3851–3851. 7 indexed citations
7.
Ames, Tyler D., et al.. (2022). Abstract 1115: PT-112 induces potent mitochondrial stress and immunogenic cell death in human prostate cancer cell lines. Cancer Research. 82(12_Supplement). 1115–1115.
8.
Moreno‐Loshuertos, Raquel, Concepción Junquera, Raquel Martínez de Mena, et al.. (2022). Characterization of differential metabolic phenotypes and PT-112-induced mitochondrial effects in human prostate cancer cells. European Journal of Cancer. 174. S39–S39. 1 indexed citations
9.
Bryce, Alan H., Roxana Dronca, Brian A. Costello, et al.. (2021). A phase 1b study of novel immunogenic cell death inducer PT-112 plus PD-L1 inhibitor avelumab in metastatic castrate-resistant prostate cancer (mCRPC) patients.. Journal of Clinical Oncology. 39(15_suppl). e17025–e17025. 4 indexed citations
10.
Kourelis, Taxiarchis, Sikander Ailawadhi, Dan T. Vogl, et al.. (2020). A Phase I Dose Escalation Study of PT-112 in Patients with Relapsed or Refractory Multiple Myeloma. Blood. 136(Supplement 1). 9–10. 4 indexed citations
11.
Yim, Christina Y., et al.. (2017). G0S2 represses PI3K/mTOR signaling and increases sensitivity to PI3K/mTOR pathway inhibitors in breast cancer. Cell Cycle. 16(21). 2146–2155. 16 indexed citations
12.
Yim, Christina Y., David Sekula, Xi Liu, et al.. (2016). G0S2 Suppresses Oncogenic Transformation by Repressing a MYC-Regulated Transcriptional Program. Cancer Research. 76(5). 1204–1213. 43 indexed citations
13.
Albany, Costantine, Christina Y. Yim, Janice Tam, et al.. (2016). Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine. Oncotarget. 8(2). 2949–2959. 56 indexed citations
14.
Yim, Christina Y., Pingping Mao, & Michael J. Spinella. (2014). Headway and Hurdles in the Clinical Development of Dietary Phytochemicals for Cancer Therapy and Prevention: Lessons Learned from Vitamin A Derivatives. The AAPS Journal. 16(2). 281–288. 4 indexed citations
15.
Yim, Christina Y., Joanna K. Soczynska, Sidney H. Kennedy, et al.. (2011). The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. European Psychiatry. 27(3). 223–228. 88 indexed citations
16.
Soczynska, Joanna K., Sidney H. Kennedy, Hanna O. Woldeyohannes, et al.. (2010). Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus. NeuroMolecular Medicine. 13(2). 93–116. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdullah Çim Breakdown of academic impact, for papers by Hyeon-Jin Kim Breakdown of academic impact, for papers by Seung Chan Kim Breakdown of academic impact, for papers by Kyosuke Yamanishi Breakdown of academic impact, for papers by Nattakarn Limphaibool Breakdown of academic impact, for papers by Qiaoyan Hu Breakdown of academic impact, for papers by Francesco Rossi Breakdown of academic impact, for papers by Xiaolin Yang Breakdown of academic impact, for papers by Lolita S. Nidadavolu Breakdown of academic impact, for papers by Tianzuo Li
Rankless by CCL
2026